Compare VFF & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VFF | CYRX |
|---|---|---|
| Founded | 1989 | 1999 |
| Country | United States | United States |
| Employees | N/A | 1100 |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 314.1M | 419.3M |
| IPO Year | 2013 | 2008 |
| Metric | VFF | CYRX |
|---|---|---|
| Price | $2.81 | $10.17 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 9 |
| Target Price | N/A | ★ $12.94 |
| AVG Volume (30 Days) | ★ 959.3K | 399.7K |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 184.38 | 156.22 |
| EPS | 0.27 | ★ 1.40 |
| Revenue | ★ $215,937,000.00 | $176,177,000.00 |
| Revenue This Year | $12.19 | $11.06 |
| Revenue Next Year | $18.08 | $8.45 |
| P/E Ratio | $10.67 | ★ $7.19 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.57 | $5.21 |
| 52 Week High | $4.99 | $11.45 |
| Indicator | VFF | CYRX |
|---|---|---|
| Relative Strength Index (RSI) | 48.93 | 72.51 |
| Support Level | $2.70 | $9.18 |
| Resistance Level | $2.94 | $10.23 |
| Average True Range (ATR) | 0.13 | 0.41 |
| MACD | 0.03 | 0.18 |
| Stochastic Oscillator | 61.64 | 94.55 |
Village Farms International Inc owns and operates intensive agricultural greenhouse facilities in British Columbia and Texas, where it produces, markets and sells tomatoes, bell peppers and cucumbers. Its wholly owned subsidiary, Pure Sunfarms, is a vertically integrated licensed producer and supplier of cannabis products sold to other licensed providers and provincial governments across Canada and internationally. The Company's wholly owned subsidiary, Balanced Health, develops and sells, cannabidiol (CBD) based products including ingestible, edible and topical applications. The operating segments of the Company are VF Fresh (Produce), Cannabis Canada, Cannabis U.S., Clean Energy, and Cannabis - Netherlands. The company makes majority of its revenue from the Cannabis Canada segment.
CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.